AAAAAA
Results:
1-9
|
Results: 9
Authors:
MIKHAILIDIS DP
GANOTAKIS ES
GEORGOULIAS VA
VALLANCE DT
WINDER AF
Citation: Dp. Mikhailidis et al., TAMOXIFEN-INDUCED HYPERTRIGLYCERIDEMIA - 7 CASE-REPORTS AND SUGGESTIONS FOR REMEDIAL ACTION, Oncology Reports, 4(3), 1997, pp. 625-628
Authors:
BOLODEOKU JA
GANOTAKIS ES
MIKHAILIDIS DP
WINDER AF
Citation: Ja. Bolodeoku et al., CORRELATION BETWEEN SERUM GAMMA-GLUTAMYL-TRANSFERASE ACTIVITY AND THEPLATELET COUNT, Platelets, 8(5), 1997, pp. 333-335
Authors:
MIKHAILIDIS DP
JAGROOP IA
GANOTAKIS ES
Citation: Dp. Mikhailidis et al., PATHOPHYSIOLOGY OF HEPARIN-INDUCED THROMBOCYTOPENIA (HIT), Platelets, 8(1), 1997, pp. 66-68
Authors:
GANOTAKIS ES
JAGROOP IA
HAMILTON G
WINDER AF
MIKHAILIDIS DP
Citation: Es. Ganotakis et al., PRELIMINARY-REPORT - CIPROFIBRATE-FLUVASTATIN COMBINATION THERAPY FORDYSLIPIDEMIA, Journal of drug development and clinical practice, 8(3), 1996, pp. 171-175
Authors:
GANOTAKIS ES
MIKHAILIDIS DP
Citation: Es. Ganotakis et Dp. Mikhailidis, CARDIOVASCULAR RISK FACTOR MANAGEMENT - NEW DRUGS WILL PROVIDE A BRIGHT FUTURE, Journal of drug development and clinical practice, 8(2), 1996, pp. 57-60
Authors:
MIKHAILIDIS DP
GANOTAKIS ES
Citation: Dp. Mikhailidis et Es. Ganotakis, PLASMA-ALBUMIN AND PLATELET-FUNCTION - RELEVANCE TO ATHEROGENESIS ANDTHROMBOSIS, Platelets, 7(3), 1996, pp. 125-137
Authors:
GANOTAKIS ES
MIKHAILIDIS DP
Citation: Es. Ganotakis et Dp. Mikhailidis, TOBACCO AND HEALTH - DOLL,R, CROFTON,J, Journal of the Royal Society of Health, 116(4), 1996, pp. 273-273
Authors:
MIKHAILIDIS DP
GANOTAKIS ES
JAGROOP IA
WINDER AF
Citation: Dp. Mikhailidis et al., BENEFICIAL-EFFECTS OF STATINS, Lancet, 348(9041), 1996, pp. 1582-1583
Authors:
MIKHAILIDIS DP
GANOTAKIS ES
WINDER AF
Citation: Dp. Mikhailidis et al., COMMENT ON - EFFECT OF PRAVASTATIN SODIUM AND SIMVASTATIN ON PLASMA-FIBRINOGEN LEVEL AND BLOOD RHEOLOGY IN TYPE-II HYPERLIPOPROTEINEMIA, Atherosclerosis, 127(2), 1996, pp. 287-288
Risultati:
1-9
|